Cold Atmospheric Plasma Restores Paclitaxel Sensitivity to Paclitaxel-Resistant Breast Cancer Cells by Reversing Expression of Resistance-Related Genes

Paclitaxel (Tx) is a widely used therapeutic chemical for breast cancer treatment; however, cancer recurrence remains an obstacle for improved prognosis of cancer patients. In this study, cold atmospheric plasma (CAP) was tested for its potential to overcome the drug resistance. After developing Tx-...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Sungbin, Kim, Heejoo, Ji, Hwee Won, Kim, Hyeon Woo, Yun, Sung Hwan, Choi, Eun Ha, Kim, Sun Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966695/
https://www.ncbi.nlm.nih.gov/pubmed/31847101
http://dx.doi.org/10.3390/cancers11122011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966695/
https://www.ncbi.nlm.nih.gov/pubmed/31847101
http://dx.doi.org/10.3390/cancers11122011

Ejemplares similares